Results 11 to 20 of about 155,441 (160)

Amiodarone-related Pneumonitis [PDF]

open access: yesJournal of the Formosan Medical Association, 2007
Amiodarone-related pneumonitis is a potentially limiting factor for amiodarone usage. However, it is believed that amiodarone-related pneumonitis is unlikely to occur during low-dose and short courses of therapy. We report three patients who received low-
Sheng-Nan Chang   +7 more
doaj   +2 more sources

Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer [PDF]

open access: yes, 2023
Radiation recall pneumonitis (RRP) is a rare inflammatory reaction that occurs in previously irradiated fields, and it may be caused by various triggering agents. Immunotherapy has been reported to potentially be one of these triggers.
Sara Torresan   +13 more
core   +2 more sources

Clinical characteristics of patients with COVID-19 vaccine-related pneumonitis: a case series and literature review [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2022
Background/Aims Pulmonary toxicities of coronavirus disease 2019 (COVID-19) vaccination are exceedingly rare. However, there are a few reported cases after mRNA vaccination, especially from Asian countries.
Ji Young Park   +9 more
doaj   +1 more source

Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy

open access: yesBiology, 2021
The advent of immunotherapy has changed the management and therapeutic methods for a variety of malignant tumors in the last decade. Unlike traditional cytotoxic chemotherapy, which works by interfering with cancer cell growth via various pathways and ...
Anca Bobircă   +8 more
doaj   +1 more source

Unilateral Pneumonitis and Hydropneumothorax Following Pembrolizumab [PDF]

open access: yes, 2022
A man in his 80s with metastatic melanoma presented with progressive dyspnea on exertion and dry cough after 7 cycles of pembrolizumab monotherapy. He was initially treated with antibiotics for community acquired pneumonia; however, his symptoms recurred
Christine Minerowicz   +3 more
core  

Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinoma

open access: yesRespiratory Medicine Case Reports, 2018
Pneumonitis is a serious adverse event of EGFR-TKI treatment. Although several cases of EGFR-TKI rechallenge after EGFR-TKI-induced pneumonitis have been reported, little is known about post-pneumonitis osimertinib rechallenge.
Shingo Satoh   +9 more
doaj   +1 more source

Anti‐synthetase syndrome associated interstitial lung disease after combination dual immune checkpoint inhibition

open access: yesRespirology Case Reports, 2023
Immune checkpoint inhibitors (ICIs) unleash potent anti‐tumour responses but with frequent off‐target immune‐mediated adverse events (irAE). ICIs can induce a spectrum of rheumatologic manifestations including inflammatory arthritis, Sjögren's syndrome ...
Peter T. Bell   +4 more
doaj   +1 more source

Vancomycin-Induced Organizing Pneumonia: A Case Report and Literature Review

open access: yesMedicina, 2021
The long-term administration of vancomycin has increased; however, the pulmonary adverse reactions of long-term vancomycin treatment remain under-studied.
Young-Shin Lee, Yu-Mi Lee
doaj   +1 more source

Trastuzumab-Induced Interstitial Pneumonitis [PDF]

open access: yes, 2023
Trastuzumab is a recombinant immunoglobulin G1 monoclonal antibody used to treat human epidermal growth factor receptor 2 (HER2) cancers. Trastuzumab-induced interstitial pneumonitis is a rare adverse effect reported in a few patients.
Bazan, Daniela Z.   +3 more
core   +1 more source

A Case of Hypersensitivity Pneumonitis Caused by Culture Medium of Enoki Mushrooms [PDF]

open access: yes, 2005
We report a case of hypersensitivity pneumonitis in a worker cultivating enoki mushrooms.The patient developed symptoms of cough, sputum, and dyspnea after changing the culture medium of the enoki mushrooms. Radiographic findings showed small nodules and
藤本, 圭作   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy